PEP
30
-3
SPG
41
-12
HRB
47
-4
T
27
-5
MTCH
33
-7
FLS
56
-8
TRV
27
-9
SRE
26
-12
GPC
28
-3
DRI
50
-6
AMP
43
-3
KSS
33
-3
AME
47
-4
NEM
34
-8
ESS
44
-9
MAC
51
-13
ZTS
36
-7
FLR
36
-10
JBHT
43
-7
MO
41
-6
PEP
30
-3
SPG
41
-12
HRB
47
-4
T
27
-5
MTCH
33
-7
FLS
56
-8
TRV
27
-9
SRE
26
-12
GPC
28
-3
DRI
50
-6
AMP
43
-3
KSS
33
-3
AME
47
-4
NEM
34
-8
ESS
44
-9
MAC
51
-13
ZTS
36
-7
FLR
36
-10
JBHT
43
-7
MO
41
-6
Financhill
Back

TG Therapeutics Stock Predictions

The 7 new tech giants dominating today's markets

Get Your Copy of "These 7 Stocks Will Be Magnificent in 2025" Here.
Buy
54

TGTX
TG Therapeutics

Last Price:
30.64
Seasonality Move:
63.62%

7 Day Trial

ALL ACCESS PASS

$ 7

2025 Gold Forecast: A Perfect Storm for Demand

Discover our Gold Price Outlook for 2025--FREE--here

TG Therapeutics Stock Forecast

  • Over the next 52 weeks, TG Therapeutics has on average historically risen by 60.1% based on the past 28 years of stock performance.
  • TG Therapeutics has risen higher in 12 of those 28 years over the subsequent 52-week period, corresponding to a historical accuracy of 42.86%
  • Is TG Therapeutics Stock Undervalued?
    The current TG Therapeutics [TGTX] share price is $31.06. The Score for TGTX is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • TGTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will TG Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, TG Therapeutics has on average historically risen by 60.1% based on the past 28 years of stock performance.

TG Therapeutics Stock Rating

Buy
54
TG Therapeutics (TGTX) is a Buy

Is TG Therapeutics overpriced?

  • TG Therapeutics has risen higher in 12 of those 28 years over the subsequent 52-week period, corresponding to a historical accuracy of 42.86%

TG Therapeutics Stock Price History

Is TGTX stock going to rise?

  • The current trend is moderately bearish and TGTX is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
tgtherapeutics.com

52-Week Data

52-Week High:
36.84
52-Week Low:
12.84

Prediction Charts

Market Cap:
4.83B
Price in USD:
31.06
Volume:
2.46M
Beta:
0.97

Technical Analysis

SMA50:
28.94
SMA100:
25.70
SMA200:
21.24
52-Wk Change:
70.75%

Stock Predictions

  • Is TG Therapeutics stock public?
    Yes, TG Therapeutics is a publicly traded company.
  • What is the TG Therapeutics stock quote today?
    The TG Therapeutics stock price is 31.06 USD today.
  • How to buy TG Therapeutics stock online?
    You can buy TG Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-29 35.19 34.80 35.78 34.71
Dec-2 34.66 35.09 35.20 33.75
Dec-3 35.02 33.39 35.48 33.16
Dec-4 33.37 33.88 34.33 33.30
Dec-5 33.66 33.65 34.64 33.60
Dec-6 33.82 33.93 34.75 33.63
Dec-9 33.71 32.84 34.10 32.72
Dec-10 32.94 31.67 33.50 31.53
Dec-11 32.01 31.65 32.38 31.07
Dec-12 31.80 30.69 32.29 30.46
Dec-13 30.70 32.02 32.19 30.41
Dec-16 32.21 34.40 35.01 32.05
Dec-17 34.30 33.57 35.03 33.32
Dec-18 33.45 31.06 33.90 30.41

TG Therapeutics Earnings

TG Therapeutics Earnings Report: Per Share TG Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

TG Therapeutics Forecast Revenue Growth

TG Therapeutics Stock Analysis: Historical quarterly revenues per share for TG Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.13 per share, and an increase next year of $0.72 per share.

* TG Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.